Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872473 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusion: FDG-PET stages N and M disease of NPC more accurately and sensitively than does the conventional workup. Patients with advanced node disease, particularly N3 disease, would benefit the most from FDG-PET.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Joseph Tung-Chieh M.D., M.H.A., Sheng-Chieh M.D., Tzu-Chen M.D., Ph.D., Chun-Ta M.D., Chien-Yu M.D., Kun-Ju M.D., Ph.D., I.-How M.D., Hung-Ming M.D., Yu-Chen M.D., Tsung-Ming M.D., Chung-Jan M.D., Shu-Hang M.D.,